This NHLBI SBIR Phase IIB Bridge Award grant accelerates the commercialization of innovative technologies for heart, lung, blood, and sleep disorders. Aimed at small business concerns, it addresses the funding gap between initial SBIR Phase II awards and market entry. The grant supports later-stage research and development for promising projects requiring federal regulatory approval. Its purpose is to help awardees achieve critical milestones for product commercialization, fostering partnerships with third-party investors. Preference is given to projects demonstrating strong commercial potential and the ability to secure matching investor funds, ensuring clinically relevant products reach the market efficiently.
Opportunity ID: 357230
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-26-014 |
| Funding Opportunity Title: | NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 19, 2024 |
| Last Updated Date: | Nov 19, 2024 |
| Original Closing Date for Applications: | Feb 26, 2027 |
| Current Closing Date for Applications: | Feb 26, 2027 |
| Archive Date: | Apr 03, 2027 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The Small Business Innovation Research (SBIR) Program is an important funding mechanism that the National Institutes of Health (NIH) uses to develop innovative solutions that address public health challenges. A major objective of the SBIR Program is to facilitate the commercialization of technologies developed by small business concerns (SBCs). Yet, the development of biomedical products is often impeded by a significant funding gap between the end of the SBIR Phase II award and the commercialization stage. This Notice of Funding Opportunity (NOFO) invites SBIR grant applications from SBCs to support later-stage research and development (referred to as Phase IIB) for promising projects that were previously funded by SBIR or STTR Phase II awards and will require eventual Federal regulatory approval/clearance. The goal of this NOFO and the resulting Phase IIB awards is to assist applicants in pursuing the milestone(s) necessary to advance a product to regulatory approval and commercialization by promoting partnerships between SBIR Phase II awardees and third-party investors and/or strategic partners. Projects proposed under this NOFO MUST be relevant to the NHLBI mission (see B. Scientific/Technical Scope). This NOFO is specifically intended to benefit clinical practice by accelerating the commercialization of novel products that require ultimate approval/clearance by a Federal regulatory agency. This NOFO will give competitive preference and funding priority to applications deemed likely to result in a clinically-relevant commercial product as indicated by the applicants ability to secure independent third-party investor funds that equal or exceed the requested NHLBI funds (total costs). |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-014.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357230 Full Announcement-RFA-HL-26-014 -> RFA-HL-26-014-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288813 | Jan 26, 2025 | Feb 26, 2027 | View |
Package 1
Mandatory forms
357230 RR_SF424_5_0-5.0.pdf
357230 PHS398_CoverPageSupplement_5_0-5.0.pdf
357230 RR_OtherProjectInfo_1_4-1.4.pdf
357230 PerformanceSite_4_0-4.0.pdf
357230 RR_KeyPersonExpanded_4_0-4.0.pdf
357230 RR_Budget_3_0-3.0.pdf
357230 PHS398_ResearchPlan_5_0-5.0.pdf
357230 SBIR_STTR_Information_3_0-3.0.pdf
357230 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357230 RR_SubawardBudget30_3_0-3.0.pdf
357230 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
